Similar to cancer cells and other immune‐suppressive myeloid‐derived suppressor cells, TAMs express immune checkpoint molecules, such as PD‐L1, so that leveraging their propensity for NP clearance can be strategically exploited to enhance anti‐tumor immunity. This evidence concerns the gene CD274 and neoplasm.